<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2020-08-12" version="174">
<accession>Q14721</accession>
<accession>Q14193</accession>
<name>KCNB1_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="27">Potassium voltage-gated channel subfamily B member 1</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="23">Delayed rectifier potassium channel 1</fullName>
<shortName evidence="23">DRK1</shortName>
<shortName evidence="23">h-DRK1</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="23">Voltage-gated potassium channel subunit Kv2.1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="27">KCNB1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Recept. Channels" volume="1" first="99" last="110">
<title>Cloning and characterization of a human delayed rectifier potassium channel gene.</title>
<authorList>
<person name="Albrecht B."/>
<person name="Lorra C."/>
<person name="Stocker K."/>
<person name="Pongs O."/>
</authorList>
<dbReference type="PubMed" id="8081723"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Pflugers Arch." volume="422" first="201" last="203">
<title>Heterologous expression of the human potassium channel Kv2.1 in clonal mammalian cells by direct cytoplasmic microinjection of cRNA.</title>
<authorList>
<person name="Ikeda S.R."/>
<person name="Soler F."/>
<person name="Zuhlke R.D."/>
<person name="Joho R.H."/>
<person name="Lewis D.L."/>
</authorList>
<dbReference type="PubMed" id="1283219"/>
<dbReference type="DOI" id="10.1007/bf00370422"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Brain cortex</tissue>
</source>
</reference>
<reference key="3">
<citation type="book" date="1998" name="The eye's aqueous humor-from secretion to glaucoma" first="69" last="104" publisher="Academic Press" city="San Diego">
<title>Identification of potassium channels in human lens epithelium.</title>
<editorList>
<person name="Civan M.M."/>
</editorList>
<authorList>
<person name="Rae J.L."/>
<person name="Shepard A.R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Lens epithelium</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="Am. J. Physiol." volume="277" first="C412" last="C424">
<title>Electrically silent potassium channel subunits from human lens epithelium.</title>
<authorList>
<person name="Shepard A.R."/>
<person name="Rae J.L."/>
</authorList>
<dbReference type="PubMed" id="10484328"/>
<dbReference type="DOI" id="10.1152/ajpcell.1999.277.3.c412"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Ann. N. Y. Acad. Sci." volume="868" first="233" last="285">
<title>Molecular diversity of K+ channels.</title>
<authorList>
<person name="Coetzee W.A."/>
<person name="Amarillo Y."/>
<person name="Chiu J."/>
<person name="Chow A."/>
<person name="Lau D."/>
<person name="McCormack T."/>
<person name="Moreno H."/>
<person name="Nadal M.S."/>
<person name="Ozaita A."/>
<person name="Pountney D."/>
<person name="Saganich M."/>
<person name="Vega-Saenz de Miera E."/>
<person name="Rudy B."/>
</authorList>
<dbReference type="PubMed" id="10414301"/>
<dbReference type="DOI" id="10.1111/j.1749-6632.1999.tb11293.x"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="FEBS Lett." volume="512" first="230" last="234">
<title>Molecular cloning and characterization of Kv6.3, a novel modulatory subunit for voltage-gated K(+) channel Kv2.1.</title>
<authorList>
<person name="Sano Y."/>
<person name="Mochizuki S."/>
<person name="Miyake A."/>
<person name="Kitada C."/>
<person name="Inamura K."/>
<person name="Yokoi H."/>
<person name="Nozawa K."/>
<person name="Matsushime H."/>
<person name="Furuichi K."/>
</authorList>
<dbReference type="PubMed" id="11852086"/>
<dbReference type="DOI" id="10.1016/s0014-5793(02)02267-6"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH KCNG3</scope>
<scope>SELF-ASSOCIATION</scope>
<scope>DOMAIN</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Mol. Endocrinol." volume="16" first="2452" last="2461">
<title>Synaptosome-associated protein of 25 kilodaltons modulates Kv2.1 voltage-dependent K(+) channels in neuroendocrine islet beta-cells through an interaction with the channel N terminus.</title>
<authorList>
<person name="MacDonald P.E."/>
<person name="Wang G."/>
<person name="Tsuk S."/>
<person name="Dodo C."/>
<person name="Kang Y."/>
<person name="Tang L."/>
<person name="Wheeler M.B."/>
<person name="Cattral M.S."/>
<person name="Lakey J.R."/>
<person name="Salapatek A.M."/>
<person name="Lotan I."/>
<person name="Gaisano H.Y."/>
</authorList>
<dbReference type="PubMed" id="12403834"/>
<dbReference type="DOI" id="10.1210/me.2002-0058"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="7986" last="7991">
<title>Obligatory heterotetramerization of three previously uncharacterized Kv channel alpha-subunits identified in the human genome.</title>
<authorList>
<person name="Ottschytsch N."/>
<person name="Raes A."/>
<person name="Van Hoorick D."/>
<person name="Snyders D.J."/>
</authorList>
<dbReference type="PubMed" id="12060745"/>
<dbReference type="DOI" id="10.1073/pnas.122617999"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH KCNG3; KCNH1 AND KCNH2</scope>
<scope>SELF-ASSOCIATION</scope>
<scope>DOMAIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Chem. Res. Toxicol." volume="16" first="1217" last="1225">
<title>Structural basis of binding and inhibition of novel tarantula toxins in mammalian voltage-dependent potassium channels.</title>
<authorList>
<person name="Shiau Y.S."/>
<person name="Huang P.T."/>
<person name="Liou H.H."/>
<person name="Liaw Y.C."/>
<person name="Shiau Y.Y."/>
<person name="Lou K.L."/>
</authorList>
<dbReference type="PubMed" id="14565763"/>
<dbReference type="DOI" id="10.1021/tx0341097"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="12769" last="12778">
<title>The Roles of N- and C-terminal determinants in the activation of the Kv2.1 potassium channel.</title>
<authorList>
<person name="Ju M."/>
<person name="Stevens L."/>
<person name="Leadbitter E."/>
<person name="Wray D."/>
</authorList>
<dbReference type="PubMed" id="12560340"/>
<dbReference type="DOI" id="10.1074/jbc.m212973200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SELF-ASSOCIATION</scope>
<scope>DOMAIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF GLU-71 AND ASP-79</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Diabetes" volume="53" first="597" last="607">
<title>Expression of voltage-gated potassium channels in human and rhesus pancreatic islets.</title>
<authorList>
<person name="Yan L."/>
<person name="Figueroa D.J."/>
<person name="Austin C.P."/>
<person name="Liu Y."/>
<person name="Bugianesi R.M."/>
<person name="Slaughter R.S."/>
<person name="Kaczorowski G.J."/>
<person name="Kohler M.G."/>
</authorList>
<dbReference type="PubMed" id="14988243"/>
<dbReference type="DOI" id="10.2337/diabetes.53.3.597"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Cell Biochem. Biophys." volume="42" first="167" last="195">
<title>Molecular determinants of voltage-gated potassium currents in vascular smooth muscle.</title>
<authorList>
<person name="Cox R.H."/>
</authorList>
<dbReference type="PubMed" id="15858231"/>
<dbReference type="DOI" id="10.1385/cbb:42:2:167"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Am. J. Physiol." volume="296" first="C1271" last="C1278">
<title>Kv2.1 and silent Kv subunits underlie the delayed rectifier K+ current in cultured small mouse DRG neurons.</title>
<authorList>
<person name="Bocksteins E."/>
<person name="Raes A.L."/>
<person name="Van de Vijver G."/>
<person name="Bruyns T."/>
<person name="Van Bogaert P.P."/>
<person name="Snyders D.J."/>
</authorList>
<dbReference type="PubMed" id="19357235"/>
<dbReference type="DOI" id="10.1152/ajpcell.00088.2009"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="4695" last="4704">
<title>Mutation of histidine 105 in the T1 domain of the potassium channel Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4.</title>
<authorList>
<person name="Mederos y Schnitzler M."/>
<person name="Rinne S."/>
<person name="Skrobek L."/>
<person name="Renigunta V."/>
<person name="Schlichthorl G."/>
<person name="Derst C."/>
<person name="Gudermann T."/>
<person name="Daut J."/>
<person name="Preisig-Muller R."/>
</authorList>
<dbReference type="PubMed" id="19074135"/>
<dbReference type="DOI" id="10.1074/jbc.m808786200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH KCNG4</scope>
<scope>SELF-ASSOCIATION</scope>
<scope>DOMAIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF HIS-105</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="31625" last="31634">
<title>Conserved negative charges in the N-terminal tetramerization domain mediate efficient assembly of Kv2.1 and Kv2.1/Kv6.4 channels.</title>
<authorList>
<person name="Bocksteins E."/>
<person name="Labro A.J."/>
<person name="Mayeur E."/>
<person name="Bruyns T."/>
<person name="Timmermans J.P."/>
<person name="Adriaensen D."/>
<person name="Snyders D.J."/>
</authorList>
<dbReference type="PubMed" id="19717558"/>
<dbReference type="DOI" id="10.1074/jbc.m109.039479"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ASP-74 AND ASP-75</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="J. Cell Sci." volume="122" first="775" last="779">
<title>SUMOylation regulates Kv2.1 and modulates pancreatic beta-cell excitability.</title>
<authorList>
<person name="Dai X.Q."/>
<person name="Kolic J."/>
<person name="Marchi P."/>
<person name="Sipione S."/>
<person name="Macdonald P.E."/>
</authorList>
<dbReference type="PubMed" id="19223394"/>
<dbReference type="DOI" id="10.1242/jcs.036632"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUMOYLATION</scope>
<scope>DESUMOYLATION</scope>
<scope>INTERACTION WITH SUMO1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="J. Pharmacol. Exp. Ther." volume="344" first="407" last="416">
<title>The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the regulation of insulin and somatostatin release from pancreatic islets.</title>
<authorList>
<person name="Li X.N."/>
<person name="Herrington J."/>
<person name="Petrov A."/>
<person name="Ge L."/>
<person name="Eiermann G."/>
<person name="Xiong Y."/>
<person name="Jensen M.V."/>
<person name="Hohmeier H.E."/>
<person name="Newgard C.B."/>
<person name="Garcia M.L."/>
<person name="Wagner M."/>
<person name="Zhang B.B."/>
<person name="Thornberry N.A."/>
<person name="Howard A.D."/>
<person name="Kaczorowski G.J."/>
<person name="Zhou Y.P."/>
</authorList>
<dbReference type="PubMed" id="23161216"/>
<dbReference type="DOI" id="10.1124/jpet.112.199083"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2014" name="J. Comp. Neurol." volume="522" first="2594" last="2608">
<title>A unique ion channel clustering domain on the axon initial segment of mammalian neurons.</title>
<authorList>
<person name="King A.N."/>
<person name="Manning C.F."/>
<person name="Trimmer J.S."/>
</authorList>
<dbReference type="PubMed" id="24477962"/>
<dbReference type="DOI" id="10.1002/cne.23551"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="E98960" last="E98960">
<title>The subfamily-specific interaction between Kv2.1 and Kv6.4 subunits is determined by interactions between the N- and C-termini.</title>
<authorList>
<person name="Bocksteins E."/>
<person name="Mayeur E."/>
<person name="Van Tilborg A."/>
<person name="Regnier G."/>
<person name="Timmermans J.P."/>
<person name="Snyders D.J."/>
</authorList>
<dbReference type="PubMed" id="24901643"/>
<dbReference type="DOI" id="10.1371/journal.pone.0098960"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH KCNG4</scope>
<scope>SELF-ASSOCIATION</scope>
<scope>DOMAIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ASP-74 AND ASP-75</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="Ann. Neurol." volume="76" first="529" last="540">
<title>De novo KCNB1 mutations in epileptic encephalopathy.</title>
<authorList>
<person name="Torkamani A."/>
<person name="Bersell K."/>
<person name="Jorge B.S."/>
<person name="Bjork R.L. Jr."/>
<person name="Friedman J.R."/>
<person name="Bloss C.S."/>
<person name="Cohen J."/>
<person name="Gupta S."/>
<person name="Naidu S."/>
<person name="Vanoye C.G."/>
<person name="George A.L. Jr."/>
<person name="Kearney J.A."/>
</authorList>
<dbReference type="PubMed" id="25164438"/>
<dbReference type="DOI" id="10.1002/ana.24263"/>
</citation>
<scope>VARIANTS EIEE26 ARG-347; ILE-374 AND ARG-379</scope>
<scope>CHARACTERIZATION OF VARIANTS EIEE26 ARG-347; ILE-374 AND ARG-379</scope>
<scope>INVOLVEMENT IN EIEE26</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2015" name="J. Gen. Physiol." volume="146" first="399" last="410">
<title>A novel epileptic encephalopathy mutation in KCNB1 disrupts Kv2.1 ion selectivity, expression, and localization.</title>
<authorList>
<person name="Thiffault I."/>
<person name="Speca D.J."/>
<person name="Austin D.C."/>
<person name="Cobb M.M."/>
<person name="Eum K.S."/>
<person name="Safina N.P."/>
<person name="Grote L."/>
<person name="Farrow E.G."/>
<person name="Miller N."/>
<person name="Soden S."/>
<person name="Kingsmore S.F."/>
<person name="Trimmer J.S."/>
<person name="Saunders C.J."/>
<person name="Sack J.T."/>
</authorList>
<dbReference type="PubMed" id="26503721"/>
<dbReference type="DOI" id="10.1085/jgp.201511444"/>
</citation>
<scope>VARIANT EIEE26 ALA-378</scope>
<scope>CHARACTERIZATION OF VARIANT EIEE26 ALA-378</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2015" name="Sci. Rep." volume="5" first="15199" last="15199">
<title>De novo KCNB1 mutations in infantile epilepsy inhibit repetitive neuronal firing.</title>
<authorList>
<person name="Saitsu H."/>
<person name="Akita T."/>
<person name="Tohyama J."/>
<person name="Goldberg-Stern H."/>
<person name="Kobayashi Y."/>
<person name="Cohen R."/>
<person name="Kato M."/>
<person name="Ohba C."/>
<person name="Miyatake S."/>
<person name="Tsurusaki Y."/>
<person name="Nakashima M."/>
<person name="Miyake N."/>
<person name="Fukuda A."/>
<person name="Matsumoto N."/>
</authorList>
<dbReference type="PubMed" id="26477325"/>
<dbReference type="DOI" id="10.1038/srep15199"/>
</citation>
<scope>VARIANTS EIEE26 CYS-306 AND ARG-401</scope>
<scope>CHARACTERIZATION OF VARIANTS EIEE26 CYS-306 AND ARG-401</scope>
</reference>
<comment type="function">
<text evidence="1 3 4 5 6 8 9 12 15 16 18 22">Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain, but also in the pancreas and cardiovascular system. Contributes to the regulation of the action potential (AP) repolarization, duration and frequency of repetitive AP firing in neurons, muscle cells and endocrine cells and plays a role in homeostatic attenuation of electrical excitability throughout the brain (PubMed:23161216). Plays also a role in the regulation of exocytosis independently of its electrical function (By similarity). Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane. Homotetrameric channels mediate a delayed-rectifier voltage-dependent outward potassium current that display rapid activation and slow inactivation in response to membrane depolarization (PubMed:8081723, PubMed:1283219, PubMed:10484328, PubMed:12560340, PubMed:19074135, PubMed:19717558, PubMed:24901643). Can form functional homotetrameric and heterotetrameric channels that contain variable proportions of KCNB2; channel properties depend on the type of alpha subunits that are part of the channel (By similarity). Can also form functional heterotetrameric channels with other alpha subunits that are non-conducting when expressed alone, such as KCNF1, KCNG1, KCNG3, KCNG4, KCNH1, KCNH2, KCNS1, KCNS2, KCNS3 and KCNV1, creating a functionally diverse range of channel complexes (PubMed:10484328, PubMed:11852086, PubMed:12060745, PubMed:19074135, PubMed:19717558, PubMed:24901643). Heterotetrameric channel activity formed with KCNS3 show increased current amplitude with the threshold for action potential activation shifted towards more negative values in hypoxic-treated pulmonary artery smooth muscle cells (By similarity). Channel properties are also modulated by cytoplasmic ancillary beta subunits such as AMIGO1, KCNE1, KCNE2 and KCNE3, slowing activation and inactivation rate of the delayed rectifier potassium channels (By similarity). In vivo, membranes probably contain a mixture of heteromeric potassium channel complexes, making it difficult to assign currents observed in intact tissues to any particular potassium channel family member. Major contributor to the slowly inactivating delayed-rectifier voltage-gated potassium current in neurons of the central nervous system, sympathetic ganglion neurons, neuroendocrine cells, pancreatic beta cells, cardiomyocytes and smooth muscle cells. Mediates the major part of the somatodendritic delayed-rectifier potassium current in hippocampal and cortical pyramidal neurons and sympathetic superior cervical ganglion (CGC) neurons that acts to slow down periods of firing, especially during high frequency stimulation. Plays a role in the induction of long-term potentiation (LTP) of neuron excitability in the CA3 layer of the hippocampus (By similarity). Contributes to the regulation of glucose-induced action potential amplitude and duration in pancreatic beta cells, hence limiting calcium influx and insulin secretion (PubMed:23161216). Plays a role in the regulation of resting membrane potential and contraction in hypoxia-treated pulmonary artery smooth muscle cells. May contribute to the regulation of the duration of both the action potential of cardiomyocytes and the heart ventricular repolarization QT interval. Contributes to the pronounced pro-apoptotic potassium current surge during neuronal apoptotic cell death in response to oxidative injury. May confer neuroprotection in response to hypoxia/ischemic insults by suppressing pyramidal neurons hyperexcitability in hippocampal and cortical regions (By similarity). Promotes trafficking of KCNG3, KCNH1 and KCNH2 to the cell surface membrane, presumably by forming heterotetrameric channels with these subunits (PubMed:12060745). Plays a role in the calcium-dependent recruitment and release of fusion-competent vesicles from the soma of neurons, neuroendocrine and glucose-induced pancreatic beta cells by binding key components of the fusion machinery in a pore-independent manner (By similarity).</text>
</comment>
<comment type="activity regulation">
<text evidence="1 9 10 22 25 26">Inhibited by 12.7 nM stromatoxin 1 (ScTx1), a spider venom toxin of the tarantula S.calceata (PubMed:14565763). Inhibited by 42 nM hanatoxin 1 (HaTx1), a spider venom toxin of the tarantula G.spatulata (PubMed:14565763). Modestly sensitive to millimolar levels of tetraethylammonium (TEA) (PubMed:8081723, PubMed:1283219). Modestly sensitive to millimolar levels of 4-aminopyridine (4-AP). Completely insensitive to toxins such as dendrotoxin (DTX) and charybdotoxin (CTX) (By similarity).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<text evidence="4 5 9 22 25 26">Homotetrameric channels expressed in xenopus oocytes or in mammalian non-neuronal cells display delayed-rectifier voltage-dependent potassium currents which are activated during membrane depolarization, i.e within a risetime of about 20 msec (PubMed:8081723, PubMed:1283219). After that, inactivate very slowly, i.e within more than 5 sec (PubMed:8081723, PubMed:1283219). Their activation requires low threshold potentials of about -20 to -30 mV, with a midpoint activation at about 10 mV. For inactivation, the voltage at half-maximal amplitude is about -20 mV (PubMed:11852086). The time constant for recovery after inactivation is about 1.6 sec. Channels have an unitary conductance of about 8 pS (PubMed:10484328). The voltage-dependence of activation and inactivation and other channel characteristics vary depending on the experimental conditions, the expression system, the presence or absence of ancillary subunits and post-translational modifications.</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="1 3 4 5 6 8 9 12 13 14 15 18 22">Homotetramer or heterotetramer with KCNB2 (PubMed:8081723, PubMed:1283219). Heterotetramer with non-conducting channel-forming alpha subunits such as KCNF1, KCNG1, KCNG3, KCNG4, KCNH1, KCNH2, KCNS1, KCNS2, KCNS3 and KCNV1 (PubMed:10484328, PubMed:11852086, PubMed:12060745, PubMed:19357235, PubMed:19074135, PubMed:19717558, PubMed:24901643). Channel activity is regulated by association with ancillary beta subunits such as AMIGO1, KCNE1, KCNE2 and KCNE3 (By similarity). Self-associates (via N-terminus and C-terminus) (PubMed:12560340, PubMed:24901643); self-association is required to regulate trafficking, gating and C-terminal phosphorylation-dependent modulation of the channel (By similarity). Interacts (via C-terminus) with STX1A (via C-terminus); this decreases the rate of channel activation and increases the rate of channel inactivation in pancreatic beta cells, induces also neuronal apoptosis in response to oxidative injury as well as pore-independent enhancement of exocytosis in neuroendocrine cells, chromaffin cells, pancreatic beta cells and from the soma of dorsal root ganglia (DRG) neurons. Interacts (via N-terminus) with SNAP25; this decreases the rate of channel inactivation in pancreatic beta cells and also increases interaction during neuronal apoptosis in a N-methyl-D-aspartate receptor (NMDAR)-dependent manner. Interacts (via N-terminus and C-terminus) with VAMP2 (via N-terminus); stimulates channel inactivation rate. Interacts with CREB1; this promotes channel acetylation in response to stimulation of incretin hormones. Interacts (via N-terminus and C-terminus) with MYL12B. Interacts (via N-terminus) with PIAS3; this increases the number of functional channels at the cell surface (By similarity). Interacts with SUMO1 (PubMed:19223394). Interacts (via phosphorylated form) with PTPRE; this reduces phosphorylation and channel activity in heterologous cells (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4 5 6 8 9 12 13 15 17 18 21 22">Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Perikaryon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Cell projection</location>
<location evidence="17">Axon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Cell projection</location>
<location evidence="17">Dendrite</location>
</subcellularLocation>
<subcellularLocation>
<location>Membrane</location>
<topology>Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cell junction</location>
<location evidence="1">Synapse</location>
<location evidence="1">Postsynaptic cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cell junction</location>
<location evidence="1">Synapse</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cell junction</location>
<location evidence="1">Synapse</location>
<location evidence="1">Synaptosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Lateral cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cell membrane</location>
<location evidence="1">Sarcolemma</location>
</subcellularLocation>
<text evidence="1 3 6 12 17 18">Localizes to high-density somatodendritic clusters and non-clustered sites on the surface of neocortical and hippocampal pyramidal neurons in a cortical actin cytoskeleton-dependent manner (PubMed:24477962). Localizes also to high-density clusters in the axon initial segment (AIS), at ankyrin-G-deficient sites, on the surface of neocortical and hippocampal pyramidal neurons (PubMed:24477962). KCNB1-containing AIS clusters localize either in close apposition to smooth endoplasmic reticulum cisternal organelles or with GABA-A receptor-containing synapses of hippocampal and cortical pyramidal neurons, respectively (PubMed:24477962). Localizes to high-density clusters on the cell surface of atrial and ventricular myocytes and at the lateral plasma membrane in epithelial cells. Localizes both to the axial and transverse tubules (T tubule) and sarcolemma in ventricular myocytes. Associated with lipid raft domains. In cortical neurons, apoptotic injuries induce de novo plasma membrane insertion in a SNARE-dependent manner causing an apoptotic potassium current surge.</text>
</comment>
<comment type="tissue specificity">
<text evidence="7 11 12 17">Expressed in neocortical pyramidal cells (PubMed:24477962). Expressed in pancreatic beta cells (at protein level) (PubMed:12403834, PubMed:14988243). Expressed in brain, heart, lung, liver, colon, kidney and adrenal gland (PubMed:19074135). Expressed in the cortex, amygdala, cerebellum, pons, thalamus, hypothalamus, hippocampus and substantia nigra (PubMed:19074135).</text>
</comment>
<comment type="domain">
<text evidence="2">The transmembrane segment S4 functions as voltage-sensor and is characterized by a series of positively charged amino acids at every third position. Channel opening and closing is effected by a conformation change that affects the position and orientation of the voltage-sensor paddle formed by S3 and S4 within the membrane. A transmembrane electric field that is positive inside would push the positively charged S4 segment outwards, thereby opening the pore, while a field that is negative inside would pull the S4 segment inwards and close the pore. Changes in the position and orientation of S4 are then transmitted to the activation gate formed by the inner helix bundle via the S4-S5 linker region.</text>
</comment>
<comment type="domain">
<text evidence="1 5 6 8 12 18">The N-terminal and C-terminal cytoplasmic regions mediate homooligomerization; self-association is required to regulate trafficking, gating and C-terminal phosphorylation-dependent modulation of the channel (PubMed:11852086, PubMed:12060745, PubMed:12560340, PubMed:19074135, PubMed:24901643). The N-terminal cytoplasmic region is important for interaction with other channel-forming alpha subunits and with ancillary beta subunits (PubMed:24901643). The C-terminus is necessary and sufficient for the restricted localization to, and clustering within, both in soma and proximal portions of dendrite of neurons and in lateral membrane of non-neuronal polarized cells. The C-terminus is both necessary and sufficient as a mediator of cholinergic and calcium-stimulated modulation of channel cell membrane clustering localization and activity in hippocampal neurons (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="1 3">Phosphorylated. Differential C-terminal phosphorylation on a subset of serines allows graded activity-dependent regulation of channel gating in hippocampal neurons. Ser-607 and Tyr-128 are significant sites of voltage-gated regulation through phosphorylation/dephosphorylation activities. Tyr-128 can be phosphorylated by Src and dephosphorylated by cytoplasmic form of the phosphatase PTPRE. CDK5-induced Ser-607 phosphorylation increases in response to acute blockade of neuronal activity. Phosphorylated on Tyr-128 by Src and on Ser-805 by MAPK14/P38MAPK; phosphorylations are necessary and sufficient for an increase in plasma membrane insertion, apoptotic potassium current surge and completion of the neuronal cell death program. Phosphorylated on Ser-520, Ser-607, Ser-656 and Ser-805 by CDK5; phosphorylation is necessary for KCNB1 channel clustering formation. The Ser-607 phosphorylation state differs between KCNB1-containing clusters on the proximal and distal portions of the axon initial segment (AIS). Highly phosphorylated on serine residues in the C-terminal cytoplasmic tail in resting neurons. Phosphorylated in pancreatic beta cells in response to incretin hormones stimulation in a PKA- and RPS6KA5/MSK1-dependent signaling pathway, promoting beta cell survival. Phosphorylation on Ser-567 is reduced during postnatal development with low levels at P2 and P5; levels then increase to reach adult levels by P14. Phosphorylation on Ser-457, Ser-541, Ser-567, Ser-607, Ser-656 and Ser-720 as well as the N-terminal Ser-15 are sensitive to calcineurin-mediated dephosphorylation contributing to the modulation of the voltage-dependent gating properties. Dephosphorylation by phosphatase PTPRE confers neuroprotection by its inhibitory influence on the neuronal apoptotic potassium current surge in a Zn(2+)-dependent manner. Dephosphorylated at Ser-607 by protein phosphatase PPP1CA. Hypoxia-, seizure- or glutamate-induced neuronal activity promote calcium/calcineurin-dependent dephosphorylation resulting in a loss of KCNB1-containing clustering and enhanced channel activity. In response to brain ischemia, Ser-567 and Ser-607 are strongly dephosphorylated while Ser-457 and Ser-720 are less dephosphorylated. In response to brain seizures, phosphorylation levels on Ser-567 and Ser-607 are greatly reduced. Phosphorylated/dephosphorylated by Src or FYN tyrosine-protein kinases and tyrosine phosphatase PTPRE in primary Schwann cells and sciatic nerve tissue (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="1">Acetylated. Acetylation occurs in pancreatic beta cells in response to stimulation by incretin hormones in a histone acetyltransferase (HAT)/histone deacetylase (HDAC)-dependent signaling pathway, promoting beta cell survival.</text>
</comment>
<comment type="PTM">
<text evidence="13">Sumoylated on Lys-474, preferentially with SUMO1; sumoylation induces a positive shift in the voltage-dependence of activation and inhibits channel activity (PubMed:19223394). Sumoylation increases the frequency of repetitive action potential firing at the cell surface of hippocampal neurons and decreases its frequency in pancreatic beta cells (PubMed:19223394). Desumoylated by SENP1 (PubMed:19223394).</text>
</comment>
<comment type="disease" evidence="19 20 21">
<disease id="DI-04249">
<name>Epileptic encephalopathy, early infantile, 26</name>
<acronym>EIEE26</acronym>
<description>A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE26 patients manifest multiple types of seizures, delayed psychomotor development, poor or absent speech, hypotonia, hypsarrhythmia.</description>
<dbReference type="MIM" id="616056"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="24">Belongs to the potassium channel family. B (Shab) (TC 1.A.1.2) subfamily. Kv2.1/KCNB1 sub-subfamily.</text>
</comment>
<comment type="sequence caution" evidence="24">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAA36156" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="X68302">
<property type="protein sequence ID" value="CAA48374.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L02840">
<property type="protein sequence ID" value="AAA36156.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF026005">
<property type="protein sequence ID" value="AAB88808.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL035685">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13418.1"/>
<dbReference type="PIR" id="S31761">
<property type="entry name" value="S31761"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004966.1">
<property type="nucleotide sequence ID" value="NM_004975.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006723847.1">
<property type="nucleotide sequence ID" value="XM_006723784.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011527101.1">
<property type="nucleotide sequence ID" value="XM_011528799.2"/>
</dbReference>
<dbReference type="BioGRID" id="109947">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="CORUM" id="Q14721"/>
<dbReference type="IntAct" id="Q14721">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000360806"/>
<dbReference type="BindingDB" id="Q14721"/>
<dbReference type="ChEMBL" id="CHEMBL2363000"/>
<dbReference type="DrugBank" id="DB06637">
<property type="generic name" value="Dalfampridine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01069">
<property type="generic name" value="Promethazine"/>
</dbReference>
<dbReference type="DrugCentral" id="Q14721"/>
<dbReference type="GuidetoPHARMACOLOGY" id="546"/>
<dbReference type="TCDB" id="1.A.1.2.11">
<property type="family name" value="the voltage-gated ion channel (vic) superfamily"/>
</dbReference>
<dbReference type="iPTMnet" id="Q14721"/>
<dbReference type="PhosphoSitePlus" id="Q14721"/>
<dbReference type="BioMuta" id="KCNB1"/>
<dbReference type="DMDM" id="24418854"/>
<dbReference type="OGP" id="Q14721"/>
<dbReference type="MassIVE" id="Q14721"/>
<dbReference type="MaxQB" id="Q14721"/>
<dbReference type="PaxDb" id="Q14721"/>
<dbReference type="PeptideAtlas" id="Q14721"/>
<dbReference type="PRIDE" id="Q14721"/>
<dbReference type="ProteomicsDB" id="60144"/>
<dbReference type="Antibodypedia" id="28477">
<property type="antibodies" value="382 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3745"/>
<dbReference type="Ensembl" id="ENST00000371741">
<property type="protein sequence ID" value="ENSP00000360806"/>
<property type="gene ID" value="ENSG00000158445"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000635465">
<property type="protein sequence ID" value="ENSP00000489193"/>
<property type="gene ID" value="ENSG00000158445"/>
</dbReference>
<dbReference type="GeneID" id="3745"/>
<dbReference type="KEGG" id="hsa:3745"/>
<dbReference type="UCSC" id="uc002xur.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3745"/>
<dbReference type="DisGeNET" id="3745"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000158445.8"/>
<dbReference type="GeneCards" id="KCNB1"/>
<dbReference type="HGNC" id="HGNC:6231">
<property type="gene designation" value="KCNB1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000158445">
<property type="expression patterns" value="Tissue enhanced (brain, retina)"/>
</dbReference>
<dbReference type="MalaCards" id="KCNB1"/>
<dbReference type="MIM" id="600397">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616056">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14721"/>
<dbReference type="OpenTargets" id="ENSG00000158445"/>
<dbReference type="Orphanet" id="442835">
<property type="disease" value="Undetermined early-onset epileptic encephalopathy"/>
</dbReference>
<dbReference type="PharmGKB" id="PA209"/>
<dbReference type="eggNOG" id="KOG3713">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154899"/>
<dbReference type="HOGENOM" id="CLU_011722_2_1_1"/>
<dbReference type="InParanoid" id="Q14721"/>
<dbReference type="KO" id="K04885"/>
<dbReference type="OMA" id="AFNFHDA"/>
<dbReference type="OrthoDB" id="203440at2759"/>
<dbReference type="PhylomeDB" id="Q14721"/>
<dbReference type="TreeFam" id="TF313103"/>
<dbReference type="PathwayCommons" id="Q14721"/>
<dbReference type="Reactome" id="R-HSA-1296072">
<property type="pathway name" value="Voltage gated Potassium channels"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381676">
<property type="pathway name" value="Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"/>
</dbReference>
<dbReference type="SIGNOR" id="Q14721"/>
<dbReference type="BioGRID-ORCS" id="3745">
<property type="hits" value="3 hits in 871 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="KCNB1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="KCNB1"/>
<dbReference type="GenomeRNAi" id="3745"/>
<dbReference type="Pharos" id="Q14721">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:Q14721"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="RNAct" id="Q14721">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000158445">
<property type="expression patterns" value="Expressed in frontal cortex and 198 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q14721">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14721">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032590">
<property type="term" value="C:dendrite membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016328">
<property type="term" value="C:lateral plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0032809">
<property type="term" value="C:neuronal cell body membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043204">
<property type="term" value="C:perikaryon"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042383">
<property type="term" value="C:sarcolemma"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0008076">
<property type="term" value="C:voltage-gated potassium channel complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005251">
<property type="term" value="F:delayed rectifier potassium channel activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044325">
<property type="term" value="F:ion channel binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005249">
<property type="term" value="F:voltage-gated potassium channel activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001508">
<property type="term" value="P:action potential"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071333">
<property type="term" value="P:cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031669">
<property type="term" value="P:cellular response to nutrient levels"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007215">
<property type="term" value="P:glutamate receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046676">
<property type="term" value="P:negative regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045956">
<property type="term" value="P:positive regulation of calcium ion-dependent exocytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033605">
<property type="term" value="P:positive regulation of catecholamine secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900454">
<property type="term" value="P:positive regulation of long-term synaptic depression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010701">
<property type="term" value="P:positive regulation of norepinephrine secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090314">
<property type="term" value="P:positive regulation of protein targeting to membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071805">
<property type="term" value="P:potassium ion transmembrane transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051260">
<property type="term" value="P:protein homooligomerization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0072659">
<property type="term" value="P:protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098900">
<property type="term" value="P:regulation of action potential"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050796">
<property type="term" value="P:regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034765">
<property type="term" value="P:regulation of ion transmembrane transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:2000671">
<property type="term" value="P:regulation of motor neuron apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006904">
<property type="term" value="P:vesicle docking involved in exocytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.120.350">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000210">
<property type="entry name" value="BTB/POZ_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR005821">
<property type="entry name" value="Ion_trans_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR003968">
<property type="entry name" value="K_chnl_volt-dep_Kv"/>
</dbReference>
<dbReference type="InterPro" id="IPR003973">
<property type="entry name" value="K_chnl_volt-dep_Kv2"/>
</dbReference>
<dbReference type="InterPro" id="IPR004350">
<property type="entry name" value="K_chnl_volt-dep_Kv2.1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011333">
<property type="entry name" value="SKP1/BTB/POZ_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR003131">
<property type="entry name" value="T1-type_BTB"/>
</dbReference>
<dbReference type="InterPro" id="IPR028325">
<property type="entry name" value="VG_K_chnl"/>
</dbReference>
<dbReference type="InterPro" id="IPR027359">
<property type="entry name" value="Volt_channel_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11537">
<property type="entry name" value="PTHR11537"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02214">
<property type="entry name" value="BTB_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00520">
<property type="entry name" value="Ion_trans"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03521">
<property type="entry name" value="Kv2channel"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PRINTS" id="PR01514">
<property type="entry name" value="KV21CHANNEL"/>
</dbReference>
<dbReference type="PRINTS" id="PR01491">
<property type="entry name" value="KVCHANNEL"/>
</dbReference>
<dbReference type="PRINTS" id="PR01495">
<property type="entry name" value="SHABCHANNEL"/>
</dbReference>
<dbReference type="SMART" id="SM00225">
<property type="entry name" value="BTB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54695">
<property type="entry name" value="SSF54695"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0268">Exocytosis</keyword>
<keyword id="KW-0407">Ion channel</keyword>
<keyword id="KW-0406">Ion transport</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0628">Postsynaptic cell membrane</keyword>
<keyword id="KW-0630">Potassium</keyword>
<keyword id="KW-0631">Potassium channel</keyword>
<keyword id="KW-0633">Potassium transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0771">Synaptosome</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0851">Voltage-gated channel</keyword>
<feature type="chain" description="Potassium voltage-gated channel subfamily B member 1" id="PRO_0000054042">
<location>
<begin position="1"/>
<end position="858"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="1"/>
<end position="186"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=Segment S1" evidence="2">
<location>
<begin position="187"/>
<end position="208"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="209"/>
<end position="228"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=Segment S2" evidence="2">
<location>
<begin position="229"/>
<end position="250"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="251"/>
<end position="259"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=Segment S3" evidence="2">
<location>
<begin position="260"/>
<end position="280"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="281"/>
<end position="294"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Voltage-sensor; Name=Segment S4" evidence="2">
<location>
<begin position="295"/>
<end position="316"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="317"/>
<end position="330"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=Segment S5" evidence="2">
<location>
<begin position="331"/>
<end position="351"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="352"/>
<end position="364"/>
</location>
</feature>
<feature type="intramembrane region" description="Helical; Name=Pore helix" evidence="2">
<location>
<begin position="365"/>
<end position="376"/>
</location>
</feature>
<feature type="intramembrane region" evidence="2">
<location>
<begin position="377"/>
<end position="384"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="385"/>
<end position="391"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=Segment S6" evidence="2">
<location>
<begin position="392"/>
<end position="420"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="421"/>
<end position="858"/>
</location>
</feature>
<feature type="region of interest" description="Self-association" evidence="1">
<location>
<begin position="59"/>
<end position="75"/>
</location>
</feature>
<feature type="region of interest" description="Self-association" evidence="1">
<location>
<begin position="448"/>
<end position="481"/>
</location>
</feature>
<feature type="short sequence motif" description="Selectivity filter" evidence="2">
<location>
<begin position="377"/>
<end position="382"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="517"/>
<end position="520"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="701"/>
<end position="706"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="15"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by Src" evidence="1">
<location>
<position position="128"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="444"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="457"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="484"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="496"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="503"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="519"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5; in vitro" evidence="1">
<location>
<position position="520"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="541"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="567"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="590"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5" evidence="1">
<location>
<position position="607"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5; in vitro" evidence="1">
<location>
<position position="656"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="720"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="772"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="800"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5, MAPK14; in vitro" evidence="1">
<location>
<position position="805"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="1">
<location>
<position position="474"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE26; reduces sensitivity and cooperativity of the voltage sensor for channel opening and greatly suppresses repetitive firing in cultured cortical neurons; dbSNP:rs1555889130." id="VAR_075573" evidence="20">
<original>R</original>
<variation>C</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE26; inhibits ion selectivity and gain of a depolarizing inward cation conductance; trafficks normally to the cell surface; dbSNP:rs587777848." id="VAR_071991" evidence="19">
<original>S</original>
<variation>R</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE26; inhibits ion selectivity and gain of a depolarizing inward cation conductance; trafficks normally to the cell surface; dbSNP:rs587777849." id="VAR_071992" evidence="19">
<original>T</original>
<variation>I</variation>
<location>
<position position="374"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE26; change in the ion selectivity from potassium-selective to nonselective cation channels and significant decrease in cell membrane localization." id="VAR_075574" evidence="21">
<original>V</original>
<variation>A</variation>
<location>
<position position="378"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE26; inhibits ion selectivity and gain of a depolarizing inward cation conductance; trafficks normally to the cell surface; dbSNP:rs587777850." id="VAR_071993" evidence="19">
<original>G</original>
<variation>R</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE26; dominant-negative mutation resulting in loss of endogenous channel currents and greatly suppresses repetitive firing in cultured cortical neurons." id="VAR_075575" evidence="20">
<original>G</original>
<variation>R</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229006." id="VAR_062182">
<original>T</original>
<variation>N</variation>
<location>
<position position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229006." id="VAR_062183">
<original>T</original>
<variation>S</variation>
<location>
<position position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34467662." id="VAR_034049">
<original>P</original>
<variation>S</variation>
<location>
<position position="825"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34280195." id="VAR_062184">
<original>S</original>
<variation>N</variation>
<location>
<position position="857"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on channel activity." evidence="8">
<original>E</original>
<variation>Q</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with KCNG1 and self-interaction and impairs plasma membrane subcellular localization, homotetramerization and hetetrotetramerization with KCNG4; when associated with R-75." evidence="15 18">
<original>D</original>
<variation>R</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with KCNG1 and self-interaction and impairs plasma membrane subcellular localization, homotetramerization and hetetrotetramerization with KCNG4; when associated with R-74." evidence="15 18">
<original>D</original>
<variation>R</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases channel activity." evidence="8">
<original>D</original>
<variation>E</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces channel activity. Inhibits interaction with KCNG4. Impairs hetetrotetramerization with KCNG1, KCNG3 or KCNG4. Does not impair homotetramerization." evidence="12">
<original>H</original>
<variation>V</variation>
<variation>R</variation>
<location>
<position position="105"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P15387"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P63142"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q03717"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10484328"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11852086"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12060745"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12403834"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12560340"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1283219"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14565763"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14988243"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19074135"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19223394"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19357235"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19717558"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23161216"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24477962"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24901643"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25164438"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26477325"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26503721"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8081723"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8081723"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<evidence key="25" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10414301"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15858231"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:6231"/>
</source>
</evidence>
<sequence length="858" mass="95878" checksum="C4B426174ED0DEE4" modified="2002-10-25" version="2">MPAGMTKHGSRSTSSLPPEPMEIVRSKACSRRVRLNVGGLAHEVLWRTLDRLPRTRLGKLRDCNTHDSLLEVCDDYSLDDNEYFFDRHPGAFTSILNFYRTGRLHMMEEMCALSFSQELDYWGIDEIYLESCCQARYHQKKEQMNEELKREAETLREREGEEFDNTCCAEKRKKLWDLLEKPNSSVAAKILAIISIMFIVLSTIALSLNTLPELQSLDEFGQSTDNPQLAHVEAVCIAWFTMEYLLRFLSSPKKWKFFKGPLNAIDLLAILPYYVTIFLTESNKSVLQFQNVRRVVQIFRIMRILRILKLARHSTGLQSLGFTLRRSYNELGLLILFLAMGIMIFSSLVFFAEKDEDDTKFKSIPASFWWATITMTTVGYGDIYPKTLLGKIVGGLCCIAGVLVIALPIPIIVNNFSEFYKEQKRQEKAIKRREALERAKRNGSIVSMNMKDAFARSIEMMDIVVEKNGENMGKKDKVQDNHLSPNKWKWTKRTLSETSSSKSFETKEQGSPEKARSSSSPQHLNVQQLEDMYNKMAKTQSQPILNTKESAAQSKPKEELEMESIPSPVAPLPTRTEGVIDMRSMSSIDSFISCATDFPEATRFSHSPLTSLPSKTGGSTAPEVGWRGALGASGGRFVEANPSPDASQHSSFFIESPKSSMKTNNPLKLRALKVNFMEGDPSPLLPVLGMYHDPLRNRGSAAAAVAGLECATLLDKAVLSPESSIYTTASAKTPPRSPEKHTAIAFNFEAGVHQYIDADTDDEGQLLYSVDSSPPKSLPGSTSPKFSTGTRSEKNHFESSPLPTSPKFLRQNCIYSTEALTGKGPSGQEKCKLENHISPDVRVLPGGGAHGSTRDQSI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

